T. Andrew Crockett
2022
In 2022, T. Andrew Crockett earned a total compensation of $6.5M as Chief Executive Officer at Carbylan Therapeutics, a 181% increase compared to previous year.
Compensation breakdown
Bonus | $363,000 |
---|---|
Option Awards | $3,630,920 |
Salary | $605,000 |
Stock Awards | $1,885,275 |
Other | $12,252 |
Total | $6,496,447 |
Crockett received $3.6M in option awards, accounting for 56% of the total pay in 2022.
Crockett also received $363K in bonus, $605K in salary, $1.9M in stock awards and $12.3K in other compensation.
Rankings
In 2022, T. Andrew Crockett's compensation ranked 449th out of 5,510 executives tracked by ExecPay. In other words, Crockett earned more than 91.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 449 | 92nd |
Manufacturing | 187 | 94th |
Chemicals And Allied Products | 50 | 96th |
Drugs | 38 | 97th |
Pharmaceutical Preparations | 25 | 97th |
Crockett's colleagues
We found two more compensation records of executives who worked with T. Andrew Crockett at Carbylan Therapeutics in 2022.